23andMe gets FDA approval for at-home breast cancer risk test

23andMe gets FDA approval for at-home breast cancer risk test  wivb.com 23andMe gets FDA approval to report breast cancer risk without a doctor  The Mercury News FDA Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats  New York Times The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. - NCBI  NCBI FDA OKs 23andMe home breast cancer DNA test, with warning  NBCNews.comFull coverage

Read More ...
23andMe gets FDA approval for at-home breast cancer risk test published March 07, 2018 at 06:03PM. Original Source Link : http://wivb.com/2018/03/07/23andme-gets-fda-approval-for-at-home-breast-cancer-risk-test/

loading...